JPMorgan Chase & Co’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$20.5M Buy
474,253
+299,203
+171% +$12.9M ﹤0.01% 1722
2025
Q1
$6.05M Sell
175,050
-124,164
-41% -$4.29M ﹤0.01% 2540
2024
Q4
$8.21M Sell
299,214
-916,902
-75% -$25.2M ﹤0.01% 2388
2024
Q3
$31M Buy
1,216,116
+1,040,037
+591% +$26.5M ﹤0.01% 1441
2024
Q2
$4.46M Sell
176,079
-190,574
-52% -$4.83M ﹤0.01% 2589
2024
Q1
$11.3M Buy
366,653
+146,734
+67% +$4.54M ﹤0.01% 2044
2023
Q4
$8.88M Buy
219,919
+5,850
+3% +$236K ﹤0.01% 2201
2023
Q3
$5.64M Sell
214,069
-12,068
-5% -$318K ﹤0.01% 2348
2023
Q2
$3.89M Sell
226,137
-110,231
-33% -$1.9M ﹤0.01% 2661
2023
Q1
$5.58M Sell
336,368
-192,757
-36% -$3.2M ﹤0.01% 2363
2022
Q4
$4.03M Buy
529,125
+238,841
+82% +$1.82M ﹤0.01% 2527
2022
Q3
$2.89M Sell
290,284
-93,796
-24% -$932K ﹤0.01% 2680
2022
Q2
$3.49M Sell
384,080
-364,026
-49% -$3.3M ﹤0.01% 2643
2022
Q1
$7.59M Sell
748,106
-794,597
-52% -$8.06M ﹤0.01% 2259
2021
Q4
$25.7M Buy
1,542,703
+88,515
+6% +$1.48M ﹤0.01% 1410
2021
Q3
$68.2M Sell
1,454,188
-158,767
-10% -$7.44M 0.01% 955
2021
Q2
$98.3M Buy
1,612,955
+152,406
+10% +$9.29M 0.01% 846
2021
Q1
$90M Buy
1,460,549
+106,130
+8% +$6.54M 0.01% 839
2020
Q4
$96.3M Buy
1,354,419
+51,111
+4% +$3.63M 0.01% 723
2020
Q3
$48.4M Buy
1,303,308
+278,834
+27% +$10.3M 0.01% 908
2020
Q2
$33.4M Buy
1,024,474
+101,818
+11% +$3.32M 0.01% 984
2020
Q1
$26.8M Buy
922,656
+330,004
+56% +$9.57M 0.01% 990
2019
Q4
$20.8M Buy
592,652
+3,755
+0.6% +$132K ﹤0.01% 1345
2019
Q3
$12.6M Sell
588,897
-328,526
-36% -$7.05M ﹤0.01% 1646
2019
Q2
$25.3M Buy
+917,423
New +$25.3M ﹤0.01% 1214